Ahmed Aljabri

11PUBLICATIONS
27CO-AUTHORS
PharmacogenomicsPacific Peoples social determinants of healthCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 10, 2026
Risk Factors for Hypoglycemia in Type 2 Diabetes Mellitus Patients Using Once-Weekly Semaglutide: A Matched Case-Control Study.

|Mar 20, 2026
Factors Associated with Patient Treatment Satisfaction in Diabetes Mellitus Care Using the DTSQs: A Nationwide Cross-Sectional Study in Saudi Arabia.

Saleh F Alqifari, Palanisamy Amirthalingam, Kousalya Prabahar

|Dec 25, 2025
Medication Adherence to Semaglutide versus Empagliflozin in Adults with Type 2 Diabetes: A Retrospective Observational Study in Saudi Arabia.

Mostafa A S Ali, Palanisamy Amirthalingam, Hanan Alshareef

|Aug 27, 2025
Medication Adherence to Semaglutide Once-Weekly Injection Among Type-2 Diabetes Patients in Tabuk, Saudi Arabia - A Cross-Sectional Study.

Palanisamy Amirthalingam, Olayan Salamah Alatawi, Ahmed Mohsen Elsaid Hamdan

|Aug 19, 2025
The potential adding therapeutic effect of pentoxifylline and/or folic acid for chronic kidney disease patients: randomized controlled trial.

Amira Reda Muhammad Galal, Nahla Mohamed Teama, Karema Abu-Elfotuha

|Jul 25, 2025
Descriptive Analysis of Reported Adverse Events Associated with Vitiligo Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013-2023.

Saleh F Alqifari, Musaab Habibulla Gari, Jeff J Guo

Pageof 2

Frequent Collaborators

5 joint publications

Palanisamy Amirthalingam

5 joint publications

Saleh Fahad Alqifari

4 joint publications

Ahmed Mohsen Elsaid Hamdan

4 joint publications

Hanan Alshareef